Novel Treponema pallidum Recombinant Antigens for Syphilis Diagnostics: Current Status and Future Prospects.

Abstract

The recombinant protein technology considerably promoted the development of rapid and accurate treponema-specific laboratory diagnostics of syphilis infection. For the last ten years, the immunodominant recombinant inner membrane lipoproteins are proved to be sensitive and specific antigens for syphilis screening. However, the development of an enlarged T. pallidum antigen panel for diagnostics of early and late syphilis and differentiation of syphilis stages or cured syphilis remains as actual goal of multidisciplinary expertise. Current review revealed novel recombinant antigens: surface-exposed proteins, adhesins, and periplasmic and flagellar proteins, which are promising candidates for the improved syphilis serological diagnostics. The opportunities and limitations of diagnostic usage of these antigens are discussed and the criteria for selection of optimal antigens panel summarized.

• Authors: Aleksey Kubanov, Anastassia Runina, Dmitry Deryabin
• Journal: BioMed research international (Biomed Res Int) Vol. 2017 Pg. 1436080 ( 2017) ISSN: 2314-6141 [Electronic] United States
• PMID: 28523273 (Publication Type: Journal Article, Review)

Chemical References

• Antigens, Bacterial
• Bacterial Proteins
• Recombinant Proteins

Topics

• Antigens, Bacterial (immunology)
• Bacterial Proteins (immunology)
• Humans
• Recombinant Proteins (immunology)
• Syphilis (diagnosis, immunology, microbiology)
• Syphilis Serodiagnosis (methods)
• Treponema pallidum (immunology)